Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Antibacterial bioactive glass for European markets

26.10.2004


Two new products have been approved to European medical markets: antibacterial bioactive glass granules for remedying frontal sinus and bone defects and a bioactive glass plate for the repair of the orbital floor.



The products, registered by a Finnish biomaterials company Vivoxid Ltd are aimed at solving medical problems in the head and neck area.

Bioactive glass products hold substantial commercial potential. Bioactive glass offers a number of new application areas in the future in medicine and dentistry. Vivoxid has a wide development programme of new bioactive glass products. Tekes, the National Technology Agency of Finland, has funded Vivoxid’s R&D work.


Long-term achievement

“The first scientific studies with bioactive glass were conducted, as early as the middle of the 80’s at Åbo Akademi University (Turku, Finland) and at the University of Turku. The present achievement has been preceded by thorough clinical research at the University Hospital of Turku for over ten years”, says Vivoxid’s CEO Kauko Kurkela.

Vivoxid’s products can be used for curing frontal sinus and bone defects in the treatment of chronic infections of the frontal sinus. The material enhances the growth of new bone, sustains the formed bone and has antibacterial effects. Clinical experience from the past ten years has been very positive.

One of Vivoxid’s CE approved bioactive glass products is a solid plate for the reconstruction of a bro-ken orbital floor, often caused by sporting injuries, accidents or violence, for example.

Substantial commercial potential

Around 20 000 operations are performed worldwide in both the aforementioned indications. Although the products are currently for a niche market as registered for cranial indications, they hold substantial commercial potential after being further developed for much wider indication areas such as the ortho-paedic area.

After entering the European markets, the company intends to focus on the markets in North America, Japan and other countries.

Mira Banerjee | alfa
Further information:
http://www.tekes.fi
http://www.vivoxid.com

More articles from Health and Medicine:

nachricht New antibody analysis accelerates rational vaccine design
09.08.2018 | Scripps Research Institute

nachricht Distrust of power influences choice of medical procedures
01.08.2018 | Johannes Gutenberg-Universität Mainz

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

Im Focus: Lining up surprising behaviors of superconductor with one of the world's strongest magnets

Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur

What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...

Im Focus: World record: Fastest 3-D tomographic images at BESSY II

The quality of materials often depends on the manufacturing process. In casting and welding, for example, the rate at which melts solidify and the resulting microstructure of the alloy is important. With metallic foams as well, it depends on exactly how the foaming process takes place. To understand these processes fully requires fast sensing capability. The fastest 3D tomographic images to date have now been achieved at the BESSY II X-ray source operated by the Helmholtz-Zentrum Berlin.

Dr. Francisco Garcia-Moreno and his team have designed a turntable that rotates ultra-stably about its axis at a constant rotational speed. This really depends...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

2018 Work Research Conference

25.07.2018 | Event News

 
Latest News

'Building up' stretchable electronics to be as multipurpose as your smartphone

14.08.2018 | Information Technology

During HIV infection, antibody can block B cells from fighting pathogens

14.08.2018 | Life Sciences

First study on physical properties of giant cancer cells may inform new treatments

14.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>